A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer
Clinical trial NCT03728556 · COMPLETED
Trial details
- NCT number
- NCT03728556
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2023-04-03
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.